A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

Fox News senior medical analyst Dr. Marc Siegel discusses Health and Human Services Secretary Robert F. Kennedy Jr.

Scientists have discovered the ability to “personalize” cancer treatments using cutting-edge genetic technology - but experts ...

A new pancreatic cancer vaccine has appeared to slow disease progression and increase survival for patients in an early trial ...

A new vaccine for pancreatic cancer has shown potential in early trials, slowing disease progression and increasing survival rates. The vaccine was tested in a phase 1 trial involving 20 pancreatic ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.

A novel vaccine designed to target one of the most common cancer-driving mutations in patients with pancreatic and colorectal ...

Cylembio is a therapeutic cancer vaccine candidate that targets cells and immune-suppressive cells in the tumor microenvironment through activation and expansion of T cells against IDO1 and/or PD-L1 ...

Gastric cancer is one of the leading causes of cancer-related mortality worldwide, and peritoneal metastasis, wherein the ...

The U.S. Food and Drug Administration has approved Insmed's daily bronchiectasis pill, brensocatib, which will be sold under ...

Black and Hispanic people are more likely to be diagnosed with pancreatic cancer and more likely to die from it. Now, one drug may help fix this.